Crinetics Pharmaceuticals Inc

Financials

Flujo de caja de las actividades operativas -62.03 M-88.59 M-115.2 M-166.31 M-225.97 M-377.92 M -377.92 M Flujo de caja de las actividades de inversión 217 K-56.48 M-173.98 M-200.41 M-574.82 M173.91 M 173.91 M Flujo de caja de las actividades financieras 114.57 M252.68 M121.96 M388.94 M1.01 B40.61 M 40.61 M Flujo de caja libre -62.21 M-89.02 M-116.86 M-171 M-229.81 M-383.68 M -383.68 M

Crinetics Pharmaceuticals is a global pharmaceutical company known for developing drugs for the treatment of endocrine-related diseases. It was founded by Scott Struthers, Frank Zhu, Ana Kusnetzow, and Stephen F. Betz in 2008 and is headquartered in San Diego, California. It went public on NASDAQ in 2018.

CRNX

Financials

Crinetics Pharmaceuticals Inc

Noticias

Crinetics presenta solicitud para fármaco contra acromegalia en Brasil

El director de desarrollo y operaciones de Crinetics Pharmaceuticals dimitirá

Neurocrine Biosciences: The Song Remains The Same (NASDAQ:NBIX)

Director de Crinetics Pharma Vivaldi Coelho vende acciones por 180.000 dólares

Director de Crinetics Pharma, Vivaldi Coelho, vende acciones por $180k

Crinetics Pharma director Vivaldi Coelho sells $180k in stock

CFO de Crinetics Pharma Schilke vende acciones por 266.000 dólares

CFO de Crinetics Pharma vende acciones por $266 mil

Crinetics Pharma CFO Schilke sells $266k in stock

Citizens reduce el precio objetivo de Crinetics tras revisión de valoración

Citizens reduce precio objetivo de Crinetics por revisión de valuación

Citizens lowers Crinetics stock price target on valuation review